持续使用咪达唑仑与苯海拉明在难以镇静患者中的比较:一项随机双盲试验
该随机双盲试验纳入200例接受择期结肠镜中重度镇静的患者,在咪达唑仑5mg与芬太尼100μg未达充分镇静后,比较苯海拉明25mg与继续咪达唑仑1.5mg的镇静效果。结果显示苯海拉明组充分镇静率27% vs 咪达唑仑组65%(差值-38%,95%CI -50%至-24%,P<.0001),苯海拉明组需追加镇静或镇痛药物者更多(84% vs 68%,P=.008),离院时间相似(134 vs 129分钟)。结论为内镜医师应继续使用咪达唑仑而非换用苯海拉明。
要点
- 苯海拉明组充分镇静率27% vs 继续咪达唑仑组65%,差异显著(P<.0001)。
- 苯海拉明组需追加镇静或镇痛药物者84% vs 咪达唑仑组68%(P=.008)。
- 两组离院时间相似(134 vs 129分钟),治疗效应在各亚组一致。
核心结论
- 内镜医师在进行中度镇静时,对使用常规剂量咪达唑仑与阿片类药物未达充分镇静的患者,应继续使用咪达唑仑而非换用苯海拉明。
研究设计与样本
- 随机双盲试验,计划纳入200例(每组100例)接受择期结肠镜中度镇静的患者。
- 镇静以改良观察者警觉/镇静评估(MOAA/S)评分测量,0至5分制中3分为充分镇静。
- 咪达唑仑5mg与芬太尼100μg未达充分镇静者,随机分配至苯海拉明25mg组或继续咪达唑仑1.5mg组。
- 每次研究药物给药后3分钟评估镇静充分性;若MOAA/S为4至5分则重复给药,最多3剂。
- 主要终点为充分镇静。
主要发现
- 苯海拉明组充分镇静率27% vs 继续咪达唑仑组65%(差值-38%,95%CI -50%至-24%,P<.0001)。
- 研究药物完成后需追加镇静或镇痛药物者:苯海拉明组84% vs 咪达唑仑组68%(P=.008)。
- 恢复室离院时间两组相似(134 vs 129分钟)。
- 治疗效应在年龄≤55岁、药物滥用、苯二氮䓬类药物使用、阿片类药物使用及精神科药物使用等亚组中一致。
关键数值与推荐
- 当前指南推荐对苯二氮䓬类药物与阿片类药物联合未达充分镇静的内镜患者使用苯海拉明。
- 该试验中充分镇静定义为MOAA/S评分为3分(0至5分制)。
临床怎么用
- 作者结论认为,对常规剂量咪达唑仑与阿片类药物未达充分镇静的患者,内镜医师应继续使用咪达唑仑而非换用苯海拉明。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Current guidelines recommend diphenhydramine in patients undergoing endoscopy who are not adequately sedated with a benzodiazepine and opioid combination. Because this practice has not been adequately assessed, we performed a randomized, double-blind trial comparing diphenhydramine with continued midazolam in such patients. METHODS: Patients undergoing elective colonoscopy with moderate sedation were eligible. Sedation was measured with the Modified Observer's Assessment of Alertness/Sedation (MOAA/S) score with adequate sedation defined as 3 on a 0- to 5-point scale. Patients not adequately sedated with midazolam 5 mg and fentanyl 100 μg were randomly assigned to diphenhydramine 25 mg versus continued midazolam 1.5 mg. Adequacy of sedation was assessed 3 minutes after each study medication dose. If MOAA/S was 4 to 5, study medication was repeated, to a maximum of 3 doses. The primary endpoint was adequate sedation. RESULTS: The planned enrollment of 200 patients (100 in each study group) was attained. Adequate sedation was achieved less often with diphenhydramine than midazolam (27% vs 65%, difference = -38%; 95% CI, -50% to -24%; P < .0001). After study medications were completed, more patients required additional medication for sedation or analgesia with diphenhydramine versus midazolam (84% vs 68%, P = .008), whereas the time to discharge from the recovery unit was similar (134 vs 129 minutes). Treatment effect was consistent across subgroups including age ≤55, substance abuse, benzodiazepine use, opioid use, and psychiatric medication use. CONCLUSIONS: Endoscopists performing moderate sedation should continue midazolam rather than switching to diphenhydramine in patients who do not achieve adequate sedation with usual doses of midazolam and an opioid. (Clinical trial registration number: NCT01769586.).
引用
- Sachar H, Pichetshote N, Nandigam K, et al. Continued midazolam versus diphenhydramine in difficult-to-sedate patients: a randomized double-blind trial. Gastrointest Endosc. 2017. PMID: 28159539. doi:10.1016/j.gie.2017.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。